BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10552164)

  • 1. [Extracorporeal treatment procedures for selected ocular diseases. Comments by the DOG General Secretary].
    Kampik A
    Ophthalmologe; 1999 Oct; 96(10):683. PubMed ID: 10552164
    [No Abstract]   [Full Text] [Related]  

  • 2. [Extracorporeal treatment procedures for selected ocular diseases].
    Brunner R; Widder RA; Borberg H
    Ophthalmologe; 1999 Oct; 96(10):679-82. PubMed ID: 10552163
    [No Abstract]   [Full Text] [Related]  

  • 3. [Eye diseases--an endemic health care problem].
    Kampik A
    MMW Fortschr Med; 2014 Sep; 156(15):40. PubMed ID: 25282932
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress in ophthalmology for the elderly since the 1971 White House Congress on Aging.
    Kornzweig AL
    Mt Sinai J Med; 1980; 47(2):197-204. PubMed ID: 6967165
    [No Abstract]   [Full Text] [Related]  

  • 5. Ophthalmic problems among the elderly in Malaysia.
    Singh P
    Med J Malaysia; 1997 Sep; 52(3):213-6. PubMed ID: 10968087
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ophthalmo-diabetology in 2003].
    Guyot-Argenton C
    Journ Annu Diabetol Hotel Dieu; 2003; ():251-60. PubMed ID: 12868314
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical efficacy of haemorheological treatment using plasma exchange, selective adsorption and membrane differential filtration in maculopathy, retinal vein occlusion and uveal effusion syndrome.
    Brunner R; Widder RA; Fischer RA; Walter P; Bartz-Schmidt KU; Heimann K; Borberg H
    Transfus Sci; 1996 Dec; 17(4):493-8. PubMed ID: 10168545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vitamin D in the pathogenesis of ocular diseases.
    Skowron K; Pawlicka I; Gil K
    Folia Med Cracov; 2018; 58(2):103-118. PubMed ID: 30467438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What to expect at your eye exam.
    Randall HG
    Diabetes Self Manag; 2002; 19(4):8-10, 13-4. PubMed ID: 12533843
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of activated autoplasma on platelet aggregation in patients with vascular diseases of the fundus oculi].
    Mukha AI; Lysenko VS; Galileeva VV; Bunin AIa
    Vestn Oftalmol; 1998; 114(3):32-4. PubMed ID: 9720397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for proliferative ocular diseases.
    McFarland TJ; Zhang Y; Appukuttan B; Stout JT
    Expert Opin Biol Ther; 2004 Jul; 4(7):1053-8. PubMed ID: 15268673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte apheresis in combination with elimination of fibrinogen and plasma proteins of higher molecular weight in macular disease and in uveal effusion syndrome.
    Brunner R; Borberg H; Kadar J; Heidel M; Heidner K; Konen W
    Acta Med Austriaca; 1991; 18 Suppl 1():63-5. PubMed ID: 1950392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multicenter study in ophthalmology--importance of epidemiological study].
    Sato Y
    Nippon Ganka Gakkai Zasshi; 2004 Oct; 108(10):591-2. PubMed ID: 15559310
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent developments in ocular gene therapy.
    Borrás T
    Exp Eye Res; 2003 Jun; 76(6):643-52. PubMed ID: 12742346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of diabetic retinopathy and age-related macular degeneration.
    Pulido J
    Manag Care; 2002 Jan; 11(1 Suppl):9-11; discussion 24-7. PubMed ID: 11842590
    [No Abstract]   [Full Text] [Related]  

  • 16. [eOphthalmology: current state and future tendencies].
    Andonegui J; Serrano L; Eguzkiza A
    An Sist Sanit Navar; 2010; 33(1):79-91. PubMed ID: 20463774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [RNA interferences therapeutics: a new approach to the treatment of ocular diseases].
    Jiménez AI
    Arch Soc Esp Oftalmol; 2007 May; 82(5):261-3. PubMed ID: 17516260
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alternating magnetic field in the treatment of various eye diseases of vascular etiology].
    Vaĭnshteĭn ES; Zobina LV; Gurtovaia EE
    Oftalmol Zh; 1981; 36(6):325-8. PubMed ID: 7312261
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of chorioretinal degeneration and dystrophy].
    Munteanu G
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1989; 33(1):49-57. PubMed ID: 2527393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of the ocular complications of diabetes].
    Lavergne G
    Rev Med Liege; 1970 Jan; 25(2):44-6. PubMed ID: 5509256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.